Human Protein Atlas

Last updated
Human Protein Atlas
The Human Protein Atlas.png
Content
DescriptionThe Human Protein Atlas portal is a publicly available database with millions of high-resolution images showing the spatial distribution of proteins in normal human tissues and different cancer types, as well the sub cellular localisation in single cells.
Organisms Human
Contact
Research center KTH, UU, SciLifeLab, Sweden
Primary citation Uhlén M, et al. (January 2015). "Proteomics. Tissue-based map of the human proteome". Science. 347 (6220) 1260419. doi:10.1126/science.1260419. PMID   25613900. S2CID   802377.
Access
Website www.proteinatlas.org
Download URL www.proteinatlas.org/about/download
Tools
Web Advanced search, bulk retrieval/download
Miscellaneous
Versioning Yes
Data release
frequency
12 months
Version23
Curation policyYes – manual
Bookmarkable
entities
Yes – both individual protein entries and searches

The Human Protein Atlas (HPA) is a Swedish-based program started in 2003 with the aim to map all the human proteins in cells, tissues and organs using integration of various omics technologies, including antibody-based imaging, mass spectrometry-based proteomics, transcriptomics and systems biology. All the data in the knowledge resource is open access to allow scientists both in academia and industry to freely access the data for exploration of the human proteome. In June 2023, version 23 was launched where a new Interaction section was introduced containing human protein-protein interaction networks for more than 11,000 genes that will add new aspects in terms of protein function.

Contents

The resource now includes twelve separate sections with complementary information about all human proteins. All data has been updated on the approximately 5 million individual web pages. The Human Protein Atlas program has already contributed to several thousands of publications in the field of human biology and disease and was selected by the organization ELIXIR as a European core resource due to its fundamental importance for a wider life science community. The HPA consortium is funded by the Knut and Alice Wallenberg Foundation.

Twelve sections

The Human Protein Atlas consists of twelve sections:

Additional features

In addition to the twelve sections of HPA, exploring gene and protein expression, there are various features available at the HPA website to assist the research community, including integrated external resources, such as Metabolic Atlas, educational material and free downloadable data.

History

The Human Protein Atlas program was started in 2003 and funded by the non-profit organization Knut and Alice Wallenberg Foundation (KAW). The main site of the project is the Royal Institute of Technology (KTH), School of Engineering Sciences in Chemistry, Biotechnology and Health (Stockholm, Sweden). Additionally, the project involves research groups at Uppsala University, Karolinska Institutet, Chalmers University of Technology and Lund University, as well as several present and past international collaborations initiated with research groups in Europe, the United States, South Korea, China, and India. Professor Mathias Uhlén is the director of the program.

The research underpinning the start of the exploration of the whole human proteome in the Human Protein Atlas program was carried out in the late 1990s and early 2000s. A pilot study employing an affinity proteomics strategy using affinity-purified antibodies raised against recombinant human protein fragments was carried out for a chromosome-wide protein profiling of chromosome 21. [10] Other projects were also carried out to establish processes for parallel and automated affinity purification of mono-specific antibodies and their validation. [11] [12]

Research

Antibodies and antigens, produced in the Human Protein Atlas workflow, are used in research projects to study potential biomarkers in various diseases, such as breast cancer, prostate cancer, colon cancer, diabetes, autoimmune diseases, ovarian cancer and renal failure. [13] [14] [15] [16] [17] [18]

Researchers involved with Human Protein Atlas projects, are sharing protocols and method details in an open-access group on protocols.io. [19] A large effort is put into validating the antibody reagents used for profiling of tissues and cells, and the HPA has implemented stringent antibody validation criteria as suggested by the International Working Group for Antibody Validation (IWGAV). [20] [21] [22]

Collaborations

The Human Protein Atlas program has participated in 9 EU research projects ENGAGE, PROSPECTS, BIO_NMD, AFFINOMICS, CAGEKID, EURATRANS, ITFoM, DIRECT and PRIMES.

See also

References

  1. Uhlén M, Fagerberg L, Hallström BM, Lindskog C, Oksvold P, Mardinoglu A, et al. (January 2015). "Proteomics. Tissue-based map of the human proteome". Science. 347 (6220) 1260419. doi:10.1126/science.1260419. PMID   25613900. S2CID   802377.
  2. Sjöstedt, E; Zhong, W; Fagerberg, L; Karlsson, M; Mitsios, N; Adori, C; Oksvold, P; Edfors, F; Limiszewska, A; Hikmet, F; Huang, J; Du, Y; Lin, L; Dong, Z; Yang, L; Liu, X; Jiang, H; Xu, X; Wang, J; Yang, H; Bolund, L; Mardinoglu, A; Zhang, C; von Feilitzen, K; Lindskog, C; Pontén, F; Luo, Y; Hökfelt, T; Uhlén, M; Mulder, J (2020). "An atlas of the protein-coding genes in the human, pig, and mouse brain". Science. 367 (6482). doi:10.1126/science.aay5947. PMID   32139519. S2CID   212560645.
  3. Karlsson, M; Zhang, C; Méar, L; Zhong, W; Digre, A; Katona, B; Sjöstedt, E; Butler, L; Odeberg, J; Dusart, P; Edfors, F; Oksvold, P; von Feilitzen, K; Zwahlen, M; Arif, M; Altay, O; Li, X; Ozcan, M; Mardinoglu, A; Fagerberg, L; Mulder, J; Luo, Y; Ponten, F; Uhlén, M; Lindskog, C (July 2021). "A single-cell type transcriptomics map of human tissues". Science Advances. 7 (31). Bibcode:2021SciA....7.2169K. doi:10.1126/sciadv.abh2169. PMC   8318366 . PMID   34321199.
  4. Uhlen, M; Zhang, C; Lee, S; Sjöstedt, E; Fagerberg, L; Bidkhori, G; Benfeitas, R; Arif, M; Liu, Z; Edfors, F; Sanli, K; von Feilitzen, K; Oksvold, P; Lundberg, E; Hober, S; Nilsson, P; Mattsson, J; Schwenk, JM; Brunnström, H; Glimelius, B; Sjöblom, T; Edqvist, PH; Djureinovic, D; Micke, P; Lindskog, C; Mardinoglu, A; Ponten, F (18 August 2017). "A pathology atlas of the human cancer transcriptome". Science. 357 (6352). doi: 10.1126/science.aan2507 . PMID   28818916. S2CID   206659235.
  5. Uhlen, M; Karlsson, MJ; Zhong, W; Tebani, A; Pou, C; Mikes, J; Lakshmikanth, T; Forsström, B; Edfors, F; Odeberg, J; Mardinoglu, A; Zhang, C; von Feilitzen, K; Mulder, J; Sjöstedt, E; Hober, A; Oksvold, P; Zwahlen, M; Ponten, F; Lindskog, C; Sivertsson, Å; Fagerberg, L; Brodin, P (20 December 2019). "A genome-wide transcriptomic analysis of protein-coding genes in human blood cells". Science. 366 (6472). doi:10.1126/science.aax9198. PMID   31857451. S2CID   209424418.
  6. Uhlén, M; Karlsson, MJ; Hober, A; Svensson, AS; Scheffel, J; Kotol, D; Zhong, W; Tebani, A; Strandberg, L; Edfors, F; Sjöstedt, E; Mulder, J; Mardinoglu, A; Berling, A; Ekblad, S; Dannemeyer, M; Kanje, S; Rockberg, J; Lundqvist, M; Malm, M; Volk, AL; Nilsson, P; Månberg, A; Dodig-Crnkovic, T; Pin, E; Zwahlen, M; Oksvold, P; von Feilitzen, K; Häussler, RS; Hong, MG; Lindskog, C; Ponten, F; Katona, B; Vuu, J; Lindström, E; Nielsen, J; Robinson, J; Ayoglu, B; Mahdessian, D; Sullivan, D; Thul, P; Danielsson, F; Stadler, C; Lundberg, E; Bergström, G; Gummesson, A; Voldborg, BG; Tegel, H; Hober, S; Forsström, B; Schwenk, JM; Fagerberg, L; Sivertsson, Å (26 November 2019). "The human secretome". Science Signaling. 12 (609). doi: 10.1126/scisignal.aaz0274 . PMID   31772123. S2CID   208321549.
  7. Thul, PJ; Åkesson, L; Wiking, M; Mahdessian, D; Geladaki, A; Ait Blal, H; Alm, T; Asplund, A; Björk, L; Breckels, LM; Bäckström, A; Danielsson, F; Fagerberg, L; Fall, J; Gatto, L; Gnann, C; Hober, S; Hjelmare, M; Johansson, F; Lee, S; Lindskog, C; Mulder, J; Mulvey, CM; Nilsson, P; Oksvold, P; Rockberg, J; Schutten, R; Schwenk, JM; Sivertsson, Å; Sjöstedt, E; Skogs, M; Stadler, C; Sullivan, DP; Tegel, H; Winsnes, C; Zhang, C; Zwahlen, M; Mardinoglu, A; Pontén, F; von Feilitzen, K; Lilley, KS; Uhlén, M; Lundberg, E (26 May 2017). "A subcellular map of the human proteome". Science. 356 (6340). doi:10.1126/science.aal3321. PMID   28495876. S2CID   10744558.
  8. Orchard, S; Ammari, M; Aranda, B; Breuza, L; Briganti, L; Broackes-Carter, F; Campbell, NH; Chavali, G; Chen, C; del-Toro, N; Duesbury, M; Dumousseau, M; Galeota, E; Hinz, U; Iannuccelli, M; Jagannathan, S; Jimenez, R; Khadake, J; Lagreid, A; Licata, L; Lovering, RC; Meldal, B; Melidoni, AN; Milagros, M; Peluso, D; Perfetto, L; Porras, P; Raghunath, A; Ricard-Blum, S; Roechert, B; Stutz, A; Tognolli, M; van Roey, K; Cesareni, G; Hermjakob, H (January 2014). "The MIntAct project--IntAct as a common curation platform for 11 molecular interaction databases". Nucleic Acids Research. 42 (Database issue): D358-63. doi:10.1093/nar/gkt1115. PMC   3965093 . PMID   24234451.
  9. Robinson, JL; Kocabaş, P; Wang, H; Cholley, PE; Cook, D; Nilsson, A; Anton, M; Ferreira, R; Domenzain, I; Billa, V; Limeta, A; Hedin, A; Gustafsson, J; Kerkhoven, EJ; Svensson, LT; Palsson, BO; Mardinoglu, A; Hansson, L; Uhlén, M; Nielsen, J (24 March 2020). "An atlas of human metabolism". Science Signaling. 13 (624). doi:10.1126/scisignal.aaz1482. PMC   7331181 . PMID   32209698.
  10. Agaton C, Galli J, Höidén Guthenberg I, Janzon L, Hansson M, Asplund A, Brundell E, Lindberg S, Ruthberg I, Wester K, Wurtz D, Höög C, Lundeberg J, Ståhl S, Pontén F, Uhlén M (Jun 2003). "Affinity proteomics for systematic protein profiling of chromosome 21 gene products in human tissues". Molecular & Cellular Proteomics. 2 (6): 405–14. doi: 10.1074/mcp.M300022-MCP200 . PMID   12796447.
  11. Falk R, Agaton C, Kiesler E, Jin S, Wieslander L, Visa N, Hober S, Ståhl S (Dec 2003). "An improved dual-expression concept, generating high-quality antibodies for proteomics research". Biotechnology and Applied Biochemistry. 38 (Pt 3): 231–9. doi:10.1042/BA20030091. PMID   12875650. S2CID   43820440.
  12. Uhlén M, Björling E, Agaton C, Szigyarto CA, Amini B, Andersen E, et al. (Dec 2005). "A human protein atlas for normal and cancer tissues based on antibody proteomics". Molecular & Cellular Proteomics. 4 (12): 1920–32. doi: 10.1074/mcp.M500279-MCP200 . PMID   16127175.
  13. Jonsson L, Gaber A, Ulmert D, Uhlén M, Bjartell A, Jirström K (2011). "High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression". Diagnostic Pathology. 6: 91. doi: 10.1186/1746-1596-6-91 . PMC   3195697 . PMID   21955582.
  14. Larsson A, Fridberg M, Gaber A, Nodin B, Levéen P, Jönsson G, Uhlén M, Birgisson H, Jirström K (2012). "Validation of podocalyxin-like protein as a biomarker of poor prognosis in colorectal cancer". BMC Cancer. 12: 282. doi: 10.1186/1471-2407-12-282 . PMC   3492217 . PMID   22769594.
  15. Lindskog C, Asplund A, Engkvist M, Uhlen M, Korsgren O, Ponten F (Jun 2010). "Antibody-based proteomics for discovery and exploration of proteins expressed in pancreatic islets". Discovery Medicine. 9 (49): 565–78. PMID   20587347.
  16. Neiman M, Hedberg JJ, Dönnes PR, Schuppe-Koistinen I, Hanschke S, Schindler R, Uhlén M, Schwenk JM, Nilsson P (Nov 2011). "Plasma profiling reveals human fibulin-1 as candidate marker for renal impairment". Journal of Proteome Research. 10 (11): 4925–34. doi:10.1021/pr200286c. PMID   21888404.
  17. Nodin B, Fridberg M, Jonsson L, Bergman J, Uhlén M, Jirström K (2012). "High MCM3 expression is an independent biomarker of poor prognosis and correlates with reduced RBM3 expression in a prospective cohort of malignant melanoma". Diagnostic Pathology. 7: 82. doi: 10.1186/1746-1596-7-82 . PMC   3433373 . PMID   22805320.
  18. Schwenk JM, Igel U, Neiman M, Langen H, Becker C, Bjartell A, Ponten F, Wiklund F, Grönberg H, Nilsson P, Uhlen M (Nov 2010). "Toward next generation plasma profiling via heat-induced epitope retrieval and array-based assays". Molecular & Cellular Proteomics. 9 (11): 2497–507. doi: 10.1074/mcp.M110.001560 . PMC   2984230 . PMID   20682762.
  19. "Human Protein Atlas - research group on protocols.io". protocols.io. Retrieved 2019-12-12.
  20. Uhlen, M; Bandrowski, A; Carr, S; Edwards, A; Ellenberg, J; Lundberg, E; Rimm, DL; Rodriguez, H; Hiltke, T; Snyder, M; Yamamoto, T (October 2016). "A proposal for validation of antibodies". Nature Methods. 13 (10): 823–7. doi:10.1038/nmeth.3995. PMC   10335836 . PMID   27595404. S2CID   34259132.
  21. Edfors, F; Hober, A; Linderbäck, K; Maddalo, G; Azimi, A; Sivertsson, Å; Tegel, H; Hober, S; Szigyarto, CA; Fagerberg, L; von Feilitzen, K; Oksvold, P; Lindskog, C; Forsström, B; Uhlen, M (8 October 2018). "Enhanced validation of antibodies for research applications". Nature Communications. 9 (1): 4130. Bibcode:2018NatCo...9.4130E. doi:10.1038/s41467-018-06642-y. PMC   6175901 . PMID   30297845.
  22. Sivertsson, Å; Lindström, E; Oksvold, P; Katona, B; Hikmet, F; Vuu, J; Gustavsson, J; Sjöstedt, E; von Feilitzen, K; Kampf, C; Schwenk, JM; Uhlén, M; Lindskog, C (10 November 2020). "Enhanced Validation of Antibodies Enables the Discovery of Missing Proteins". Journal of Proteome Research. 19 (12): 4766–4781. doi:10.1021/acs.jproteome.0c00486. PMC   7723238 . PMID   33170010.